 Chembio Diagnostics Inc NASDAQ: CEMI shares are trading higher by 41 in Mondays pre-market session after the company announced the commercial launch of a test to differentiate between COVID-19 and the Flu. Chembio develops, manufactures, and commercializes point-of-care POC diagnostic tests that are used to detect or diagnose diseases. 